Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Obesity × Leuprolide × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 101 Breast Neoplasms 15 Neoplasms 6 Leiomyoma 5 Prostate Adenocarcinoma 3 Polycystic Ovary Syndrome 3 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Uveal Melanoma 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasms 1 Salivary Gland Neoplasm Duct 1 Recurrence 1 Puberty, Precocious 1 Primary Dysautonomias 1 Premenopausal Breast Cancer 1 Patient Compliance 1 PSA Level Greater Than Two 1 Obesity, Morbid 1 Obesity 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Metabolic Syndrome 1 Melanoma 1 Lymphatic Metastasis 1 Leukemia, Myeloid, Acute 1

Interventions

Exercise 22 Metformin 14 Tirzepatide 8 Diet 8 Resistance Training 7 Nutrition Assessment 7 Methods 7 Diet Therapy 7 Counseling 6 semaglutide 5 Exenatide 5 Early Intervention, Educational 5 Diet, Mediterranean 5 Caloric Restriction 5 Blood Specimen Collection 5 Surveys and Questionnaires 4 Liraglutide 4 Educational Status 4 Bariatric Surgery 4 Vitamin D 3 Standard of Care 3 Naltrexone 3 Letrozole 3 Docosahexaenoic Acids 3 Dexamethasone 3 Bupropion 3 exemestane 2 bupropion hydrochloride, naltrexone hydrochoride drug combination 2 Yoga 2 Topiramate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01422096 2018-07-19

CBS007

University of Virginia

Phase EARLY_PHASE1 Withdrawn

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡